Tideglusib Completed Phase 2 Trials for Autism Spectrum Conditions/Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02586935Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders